 <h1>Larotrectinib Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to larotrectinib: oral capsule, oral solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, larotrectinib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking larotrectinib:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry, stools</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>blurred vision</li>
<li>chills</li>
<li>cough</li>
<li>dizziness</li>
<li>falls</li>
<li>fever</li>
<li>headache</li>
<li>lower back or side pain</li>
<li>nervousness</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pounding in the ears</li>
<li>rapid weight gain</li>
<li>slow or fast heartbeat</li>
<li>sore throat</li>
<li>tightness in the chest</li>
<li>tingling of the hands or feet</li>
<li>troubled breathing</li>
<li>troubled breathing with exertion</li>
<li>ulcers, sores, or white spots in the mouth</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Chest pain or discomfort</li>
<li>chills</li>
<li>confusion</li>
<li>decreased urination</li>
<li>diarrhea</li>
<li>dry mouth</li>
<li>fainting</li>
<li>heartburn</li>
<li>increase in heart rate</li>
<li>increased thirst</li>
<li>indigestion</li>
<li>irregular heartbeat</li>
<li>itching, pain, redness, swelling, tenderness, or warmth on the skin</li>
<li>lightheadedness</li>
<li>loss of consciousness</li>
<li>muscle pain, cramps, or weakness</li>
<li>nausea</li>
<li>problems with movement, walking, or speech</li>
<li>rapid, shallow breathing</li>
<li>seizures</li>
<li>severe abdominal pain, cramping, or burning</li>
<li>stomach pain</li>
<li>sunken eyes</li>
<li>swelling of the face, ankles, or hands</li>
<li>vomiting</li>
<li>vomiting of material that looks like coffee grounds, severe and continuing</li>
<li>wrinkled skin</li>
<li>yellow skin or eyes</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of larotrectinib may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Back pain</li>
<li>constipation</li>
<li>decreased appetite</li>
<li>difficulty in moving</li>
<li>increased weight</li>
<li>joint pain or swelling</li>
<li>muscle stiffness</li>
<li>pain in the arms or legs</li>
<li>stuffy nose</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Lack or loss of strength</li>
</ul><p>
<!-- end oral capsule, oral solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to larotrectinib: oral capsule, oral solution</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (42%), hypoalbuminemia (35%), neutropenia (23%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (14%), myalgia (14%), muscular weakness (13%), back pain (12%), pain in extremity (12%)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Peripheral edema (15%), increased weight (15%), decreased appetite (13%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Delirium, memory impairment<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Hepatotoxicity (45%), Increased ALT (45%), increased AST (45%), increased alkaline phosphatase (30%)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (26%), dyspnea (18%), nasal congestion (10%)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (37%), pyrexia (18%), fall (10%)<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions (20% or greater) were fatigue, nausea, dizziness, vomiting, anemia, increased AST, cough, increased ALT, constipation, and diarrhea.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Neurotoxicity (53%), dizziness (28%), headache (14%)</p>
<p><b>Common</b> (1% to 10%): Dysarthria, gait disturbance, tremor, paresthesia</p>
<p><b>Uncommon</b> (0.1% to 1%): Grade 4 encephalopathy<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (11%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (29%), vomiting (26%), constipation (23%), diarrhea (22%), abdominal pain (13%)<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Vitrakvi (larotrectinib)." Bayer Pharmaceutical Inc, West Haven, CT. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What type of drug is Vitrakvi (larotrectinib)?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about larotrectinib</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>1 Review</li>
<li>Drug class: multikinase inhibitors</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Larotrectinib &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Vitrakvi</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Solid Tumors</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to larotrectinib: oral capsule, oral solution</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (42%), hypoalbuminemia (35%), neutropenia (23%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (14%), myalgia (14%), muscular weakness (13%), back pain (12%), pain in extremity (12%)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Peripheral edema (15%), increased weight (15%), decreased appetite (13%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Delirium, memory impairment<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Hepatotoxicity (45%), Increased ALT (45%), increased AST (45%), increased alkaline phosphatase (30%)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (26%), dyspnea (18%), nasal congestion (10%)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (37%), pyrexia (18%), fall (10%)<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions (20% or greater) were fatigue, nausea, dizziness, vomiting, anemia, increased AST, cough, increased ALT, constipation, and diarrhea.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Neurotoxicity (53%), dizziness (28%), headache (14%)</p><p><b>Common</b> (1% to 10%): Dysarthria, gait disturbance, tremor, paresthesia</p><p><b>Uncommon</b> (0.1% to 1%): Grade 4 encephalopathy<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (11%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (29%), vomiting (26%), constipation (23%), diarrhea (22%), abdominal pain (13%)<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Vitrakvi (larotrectinib)." Bayer Pharmaceutical Inc, West Haven, CT. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What type of drug is Vitrakvi (larotrectinib)?</li>
</ul><h2>More about larotrectinib</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>1 Review</li>
<li>Drug class: multikinase inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Larotrectinib &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Solid Tumors</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>